Drosoula Giantsoudi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Linear Energy Transfer | 10 | 2020 | 152 | 2.300 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 14 | 2022 | 1661 | 2.070 |
Why?
|
| Relative Biological Effectiveness | 11 | 2018 | 312 | 1.850 |
Why?
|
| Radiotherapy, Intensity-Modulated | 7 | 2022 | 801 | 1.820 |
Why?
|
| Organs at Risk | 7 | 2018 | 359 | 1.330 |
Why?
|
| Radiotherapy Dosage | 18 | 2022 | 2898 | 1.100 |
Why?
|
| Ependymoma | 4 | 2018 | 320 | 0.980 |
Why?
|
| Radiotherapy, Conformal | 3 | 2022 | 548 | 0.910 |
Why?
|
| Brain Stem | 4 | 2017 | 858 | 0.850 |
Why?
|
| Medulloblastoma | 4 | 2017 | 678 | 0.830 |
Why?
|
| Cerebellar Neoplasms | 3 | 2017 | 586 | 0.830 |
Why?
|
| Monte Carlo Method | 10 | 2018 | 1258 | 0.820 |
Why?
|
| Infratentorial Neoplasms | 2 | 2017 | 98 | 0.650 |
Why?
|
| Metals | 2 | 2019 | 719 | 0.530 |
Why?
|
| Radiometry | 5 | 2018 | 813 | 0.520 |
Why?
|
| Scattering, Radiation | 1 | 2017 | 490 | 0.490 |
Why?
|
| Radiation Injuries | 3 | 2018 | 1189 | 0.480 |
Why?
|
| Radiation Monitoring | 1 | 2015 | 103 | 0.460 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 390 | 0.420 |
Why?
|
| Artifacts | 2 | 2019 | 1911 | 0.400 |
Why?
|
| Prostheses and Implants | 3 | 2019 | 1271 | 0.390 |
Why?
|
| Protons | 2 | 2022 | 1116 | 0.370 |
Why?
|
| Spine | 1 | 2017 | 1118 | 0.340 |
Why?
|
| Algorithms | 5 | 2019 | 14032 | 0.320 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2526 | 0.310 |
Why?
|
| Spinal Cord | 1 | 2015 | 1819 | 0.280 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2018 | 882 | 0.270 |
Why?
|
| Brachytherapy | 1 | 2013 | 1223 | 0.250 |
Why?
|
| Photons | 2 | 2018 | 589 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 3 | 2017 | 2895 | 0.220 |
Why?
|
| Neoplasms | 5 | 2020 | 22173 | 0.200 |
Why?
|
| Feasibility Studies | 4 | 2019 | 5247 | 0.180 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 479 | 0.180 |
Why?
|
| Prostatic Neoplasms | 6 | 2017 | 11122 | 0.160 |
Why?
|
| Tattooing | 1 | 2019 | 57 | 0.160 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 21017 | 0.150 |
Why?
|
| Optic Nerve | 2 | 2018 | 572 | 0.150 |
Why?
|
| Chordoma | 3 | 2018 | 347 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20571 | 0.140 |
Why?
|
| Models, Biological | 1 | 2013 | 9469 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2013 | 5369 | 0.130 |
Why?
|
| Necrosis | 1 | 2020 | 1611 | 0.130 |
Why?
|
| Uncertainty | 2 | 2018 | 754 | 0.130 |
Why?
|
| Calibration | 1 | 2018 | 818 | 0.130 |
Why?
|
| Growth Plate | 1 | 2017 | 274 | 0.120 |
Why?
|
| Optic Nerve Diseases | 1 | 2018 | 342 | 0.120 |
Why?
|
| Rectum | 2 | 2016 | 892 | 0.110 |
Why?
|
| Radiography | 2 | 2015 | 6965 | 0.110 |
Why?
|
| Pelvis | 1 | 2017 | 733 | 0.100 |
Why?
|
| Esophagus | 1 | 2017 | 1033 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2017 | 1206 | 0.090 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2011 | 228 | 0.090 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1169 | 0.090 |
Why?
|
| Humans | 23 | 2022 | 761572 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 273 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 980 | 0.080 |
Why?
|
| Dental Implants | 1 | 2017 | 795 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2011 | 326 | 0.080 |
Why?
|
| Cerebellum | 1 | 2015 | 1501 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2013 | 6241 | 0.070 |
Why?
|
| Spinal Neoplasms | 1 | 2014 | 716 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1413 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 1052 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3769 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1958 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2018 | 41493 | 0.060 |
Why?
|
| Incidence | 3 | 2018 | 21355 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 9031 | 0.060 |
Why?
|
| Male | 12 | 2020 | 360842 | 0.050 |
Why?
|
| Child | 5 | 2022 | 80156 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 9002 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7047 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7529 | 0.050 |
Why?
|
| Female | 9 | 2022 | 392686 | 0.040 |
Why?
|
| Visible Human Projects | 1 | 2019 | 12 | 0.040 |
Why?
|
| Age Factors | 1 | 2017 | 18398 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39107 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20099 | 0.040 |
Why?
|
| Urinary Bladder | 2 | 2016 | 1152 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2017 | 42230 | 0.040 |
Why?
|
| Skull Neoplasms | 1 | 2018 | 173 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14666 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2020 | 590 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2022 | 655 | 0.040 |
Why?
|
| Adolescent | 4 | 2022 | 88324 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2016 | 91 | 0.030 |
Why?
|
| Chondrosarcoma | 1 | 2018 | 296 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 210 | 0.030 |
Why?
|
| Penis | 1 | 2016 | 212 | 0.030 |
Why?
|
| Young Adult | 3 | 2017 | 59255 | 0.030 |
Why?
|
| Teratoma | 1 | 2017 | 404 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 39970 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 27120 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2016 | 270 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2017 | 2927 | 0.020 |
Why?
|
| Probability | 1 | 2015 | 2477 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2011 | 213 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2644 | 0.020 |
Why?
|
| Meningioma | 1 | 2016 | 1218 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 80646 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1893 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3801 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4319 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13382 | 0.010 |
Why?
|
| Software | 1 | 2011 | 4434 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23996 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36192 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 221203 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74213 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 169310 | 0.000 |
Why?
|
| Middle Aged | 1 | 2018 | 220920 | 0.000 |
Why?
|